Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Tamsulosin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 108Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    China bans GSK's enlarged prostate med after plant inspection
    China bans GSK's enlarged prostate med after plant inspection

    01 Nov 2022

    // Kevin Dunleavy FIERCEPHARMA

    https://www.fiercepharma.com/manufacturing/china-suspends-import-gsks-avodart-after-plant-inspection

    Kevin Dunleavy FIERCEPHARMA
    01 Nov 2022
    Share Share
    Anbison Lab`s Generic Tamsulosin Hydrochloride Recieves Approval in US
    Anbison Lab`s Generic Tamsulosin Hydrochloride Recieves Approval in US

    19 Oct 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211885

    FDA
    19 Oct 2019
    Share Share
    Enforcement Report - Week of August 21, 2019
    Enforcement Report - Week of August 21, 2019

    21 Aug 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-21-2019-1566366765.pdf

    FDA
    21 Aug 2019
    Share Share
    Zydus Pharms USA Generic Dutasteride; Tamsulosin Hydrochloride Receives Tentative Approval In US
    Zydus Pharms USA Generic Dutasteride; Tamsulosin Hydrochloride Receives Tentative Approval In US

    29 May 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207769

    FDA
    29 May 2018
    Share Share
    Zydus Pharms USA Generic Dutasteride:Tamsulosin Hydrochloride Receives Approval In US
    Zydus Pharms USA Generic Dutasteride:Tamsulosin Hydrochloride Receives Approval In US

    26 May 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207769

    FDA
    26 May 2018
    Share Share
    Enforcement Report - Week of November 8, 2017
    Enforcement Report - Week of November 8, 2017

    08 Nov 2017

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-8-2017-1510120910.pdf

    FDA
    08 Nov 2017
    Share Share